Year-end Sale % OFF 
Abstract
Dr. Benjamin Bitler began his independent career at University of Colorado in January 2017. In this short Q&A he tells us about his motivation and passion for research, advice he would give to his younger self, and the attributes of cancer cells that he finds most perplexing.
Highlights
1234567890():,; Dr Benjamin Bitler began his independent career at University of Colorado in January 2017
In this short Q&A he tells us about his motivation and passion for research, advice he would give to his younger self, and the attributes of cancer cells that he finds most perplexing
Our recent work established Chromobox 2 (CBX2) as a novel epigenetic effector contributing to transcriptional reprogramming of metastatic ovarian cancer cells
Summary
Spotlight on early-career researchers: an interview with Benjamin Bitler 1234567890():,; Dr Benjamin Bitler began his independent career at University of Colorado in January 2017. In this short Q&A he tells us about his motivation and passion for research, advice he would give to his younger self, and the attributes of cancer cells that he finds most perplexing.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
